-
By Kenneth Silber |
October 1, 2009
Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...
-
By Staff Writer |
October 1, 2008
Investors added $223 billion in net new cash to stock, bond and hybrid funds in 2007, maintaining the recent robust pace of inflows to these...
-
By Vanessa Drucker |
November 1, 2007
If you can remember back to the 1950s, not only was Elvis cool, but so were dividend-paying stocks. Investors bought them primarily for their yield....